This study suggests that a greater reduction in adiponectin level over time is associated with worse attentional and emotional dysregulation symptoms. Our findings may inform innovative adiponectin-focused strategies for patients with ADHD.
Hsu et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: